Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

Marseille, France

Fabrice Barlesi is Professor of Medicine and Head of the Multidisciplinary Oncology and Therapeutic Innovations department at Aix Marseille University, France. He also coordinates the Marseille’s Early Phase Cancer Trials Centre dedicated to phases I in oncology. His main clinical interests lie in research in lung cancer especially in the field of angiogenesis, bioguided therapies and immuno-oncology (as a part of Marseille’s Immunopole).